Surgical treatments are an important consideration in the management of many movement disorders, particularly for patients refractory to medications. Increasing number of published reports have demonstrated an overall improvement in motor function, activities of daily living and quality of life particularly with deep brain stimulation. In addition the procedure is also relatively safe. In this article, we review the various types of movement disorders that may benefit from surgical intervention.
BraakHDel TrediciKRübUde VosRAISteurENH JansenBraakE. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197–211.
2.
ChaudhuriKRHealyDGSchapiraAH, National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurol. 2006;5(3):235–45.
3.
VolkmannJ. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol. 2004;21(1):6–17.
4.
KollerWCPahwaRLyonsKEAlbaneseA. Surgical treatment of Parkinson's disease. J Neurol Sci. 1999;167(1):1–10.
5.
LyonsKEPahwaR. Deep brain stimulation in Parkinson's disease. Curr Neurol Neurosci Rep. 2004;4(4):290–5.
6.
SpiegelEAWycisHT. Thalamotomy and pallidotomy for treatment of choreic movements. Acta Neurochir (Wien). 1952;2(3–4):417–22.
7.
DeuschlGSchade-BrittingerCKrackPVolkmannJSchaferHBotzelK. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896–908.
8.
Visser-VandewalleVvan der LindenCTemelYNiemanFCelikHBeulsE. Long-term motor effect of unilateral pallidal stimulation in 26 patients with advanced Parkinson disease. J Neurosurg. 2003;99(4):701–7.
9.
RussmannHGhikaJCombrementPVillemureJGBogousslavskyJBurkhardPR. L-Dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction. Neurology. 2004; 63(1):153–5.
10.
KrackPBatirAVan BlercomNChabardesSFraixVArdouinC, Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003; 349(20):1925–34.
11.
NandiDAzizTZGiladiNWinterJSteinJF. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain. 2002; 125(Pt11):2418–30.
12.
JordanLM. Initiation of locomotion in mammals. Ann N Y Acad Sci. 1998; 860:83–93.
PahapillPALozanoAM. The pedunculopontine nucleus and Parkinson's disease. Brain. 2000; 123(Pt9):1767–83.
15.
MazzonePLozanoAStanzionePGalatiSScarnatiEPeppeA. Implantation of human pedunculopontine nucleus: A safe and clinically relevant target in Parkinson's disease. Neuroreport. 2005;16(17):1877–81.
16.
OlanowCWGoetzCGKordowerJH. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003; 54(3):403–14.
17.
LouisED. Clinical practice. Essential tremor. N Engl J Med. 2001;345(12):887–91.
18.
ElbleRJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology. 2000;54(11 Suppl 4):S2–6.
19.
ElbleRJ. Essential tremor frequency decreases with time. Neurology. 2000;55(10):1547–51.
20.
BainPG. The management of tremor. J Neurol Neurosurg Psychiatry. 2002;72 (Suppl 1):i3–i9.
21.
AlusiSHGlickmanSAzizTZBainPG. Tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1999;66(2):131–4.
22.
GenyCNguyenJPPollinBFeveARicolfiFCesaroP. Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord. 1996;11(5):489–94.
23.
HooperJTaylorRPentlandBWhittleIR. A prospective study of thalamic deep brain stimulation for the treatment of movement disorders in multiple sclerosis. Br J Neurosurg. 2002;16(2):102–9.
24.
MontgomeryEBJrBakerKBKinkelRPBarnettG. Chronic thalamic stimulation for the tremor of multiple sclerosis. Neurology. 1999;53(3):625–8.
25.
SchulderMSernasTMahalickDAdlerRCookS. Thalamic stimulation in patients with multiple sclerosis. Stereotact Funct Neurosurg. 1999;72(2–4):196–201.
26.
DeuschlG. New treatment options for tremors. N Engl J Med. 2000;342(7):505–7.
27.
DeuschlGBainPBrinM. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13(Suppl 3:2–23.
28.
LorenzDDeuschlG. Update on pathogenesis and treatment of essential tremor. Curr Opin Neurol. 2007;20(4):447–52.
29.
DietrichsonPEspenE. Effects of timolol and atenolol on benign essential tremor: Placebo-controlled studies based on quantitative tremor recording. J Neurol Neurosurg Psychiatry. 1981;44(8):677–83.
30.
KollerWC. Dose-response relationship of propranolol in the treatment of essential tremor. Arch Neurol. 1986;43(1):42–3.
31.
CleevesLFindleyLJ. Propranolol and propranolol-LA in essential tremor: A double blind comparative study. J Neurol Neurosurg Psychiatry. 1988;51(3):379–84.
32.
YoungRR. Essential-familial tremor and other action tremors. Semin Neurol1982;2:386–391.
ConnorGS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology. 2002;59(1):132–4.
35.
OndoWHunterCVuongKDSchwartzKJankovicJ. Gabapentin for essential tremor: A multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000;15(4):678–82.
36.
BrinMFLyonsKEDoucetteJAdlerCHCavinessJNComellaCL. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001;56(11):1523–8.
37.
SandykR. Successful treatment of cerebellar tremor with clonazepam. Clin Pharm. 1985;4(6):615–8.
38.
TrellesLTrellesJOCastroCAltamiranoJBenzaquenM. Successful treatment of two cases of intention tremor with clonazepam. Ann Neuro. 1984;16(5):621.
39.
HiraiTMiyazakiMNakajimaHShibazakiTOhyeC. The correlation between tremor characteristics and the predicted volume of effective lesions in stereotaxic nucleus ventralis intermedius thalamotomy. Brain. 1983;106(Part 4):1001–18.
40.
NagasekiYShibazakiTHiraiTKawashimaYHiratoMWadaH. Long-term follow-up results of selective VIM-thalamotomy. J Neurosurg. 1986;65(3):296–302.
41.
MohadjerMGoerkeHMiliosEEtouAMundingerF. Longterm results of stereotaxy in the treatment of essential tremor. Stereotact Funct Neurosurg. 1990;54–55:125–9.
42.
LakieMArblasterLARobertsRCVarmaTR. Effect of stereotactic thalamic lesion on essential tremor. Lancet. 1992;340(8813):206–7.
43.
GoldmanMSAhlskogJEKellyPJ. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg. 1992;76(6):924–8.
44.
JankovicJCardosoFGrossmanRGHamiltonWJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery. 1995;37(4):680–6.
45.
BenabidALPollakPSeigneuretEHoffmannDGayEPerretJ. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien). 1993;58:39–44.
46.
BenabidALPollakPGaoDHoffmannDLimousinPGayE. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg. 1996;84(2):203–14.
47.
KollerWPahwaRBusenbarkKHubbleJWilkinsonSLangA. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol. 1997;42(3):292–9.
48.
BenabidALBenazzouzAHoffmannDLimousinPKrackPPollakP. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord. 1998;13Supp 3:119–25.
49.
LimousinPSpeelmanJDGielenFJanssensM. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry. 1999;66:289–96.
50.
TahaJMJanszenMAFavreJ. Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg. 1999;91(1):68–72.
51.
KollerWCLyonsKEWilkinsonSBPahwaR. Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor. Mov Disord. 1999;14(5):847–50.
52.
TrösterAIFieldsJAPahwaRWilkinsonSBStrait-TrösterKALyonsK. Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor. Neurology. 1999;53(8):1774–80.
53.
PahwaRLyonsKLWilkinsonSBCarpenterMATrösterAISearlJP. Bilateral thalamic stimulation for the treatment of essential tremor. Neurology. 1999;53(7):1447–50.
54.
HerzogJHamelWWenzelburgerRPōtterMPinskerMOBartussekJ. Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor. Brain. 2007;130(6):1608–25.
55.
van ManenJ. Stereotaxic operations in cases of hereditary and intention tremor. Acta Neurochir (Wien). 1974;Supp 21:49–55.
56.
GoldmanMSKellyPJ. Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor. J Neurosurg. 1992;77(2):223–9.
57.
SpeelmanJDSchuurmanPRde BieRMBoschDA. Thalamic surgery and tremor. Mov Disord1998;13Suppl 3:103–6.
58.
WishartHARobertsDWRothRMMcDonaldBCCoffeyDJMamourianA. Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: Review and case reports. J Neurol Neurosurg Psychiatry. 2003;74(10):1392–7.
59.
NandiDAzizTZ. Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor. J Clin Neurophysiol. 2004;21(1):31–39
60.
GoldmanMSKellyPJ. Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor. J Neurosurg. 1992;77(2):223–9.
61.
MiyagiYShimaFIshidoKMoriguchiMKamikasedaK. Postereoventral pallidotomy for midbrain tremor after a pontine hemorrhage. J Neurosurg. 1999;91(5):885–8.
KraussJKMohadjerMNobbeFMundingerF. The treatment of posttraumatic tremor by stereotactic surgery: Symptomatic and functional outcome in a series of 35 patients. J Neurosurg. 1994;80(5):810–9.
64.
BressmanSB. Dystonia genotypes, phenotypes, and classification. Adv Neurol. 2004;94:101–7.
65.
FahnSBressmanSBMarsdenCD. Classification of dystonia. Adv Neurol. 1998;78:1–10
66.
BurkeREFahnSMarsdenCD. Torsion dystonia: A double blind, prospective trial of high dosage trihexyphenidyl. Neurology. 1986;36(2):160–4.
67.
GreenePEShaleHFahnS. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord. 1988;3(1):46–60.
68.
GreenePEFahnS. Baclofen in the treatment of idiopathic dystonia in children. Mov Disord. 1992;7(1):48–52.
69.
JankovicJOrmanJ. Tetrabenazine treatment in dystonia, chorea, tics, and other dyskinesias. Neurology. 1988;38(3):391–4.
70.
BerardelliACurraA. Pathophysiology and treatment of cranial dystonia. Mov Disord. 2002; 17 (Suppl 2):S70–4.
71.
VidailhetMVercueilLHouetoJLKrystkowiakPBenabidALCornuP. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Medicine. 2005;352(5):459–67.
72.
CoubesPCifLEl FertitHHemmSVayssiereNSerratS. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: Long-term results. J Neurosurg. 2004;101(2):189–94.
73.
YianniJBainPGiladiNAucaMGregoryRJointC. Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit. Mov Disord. 2003;18(4):436–42.
74.
KraussJLoherTPohleTWeberSTaubEBarlocherC. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry. 2002;72(2):249–56.
75.
VidailhetMVercueilLHouetoJLKrystkowiakPBenabidALCornuP. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med2005;352(5):459–67.
76.
TrottenbergTVolkmannJDeuschlGKuhnAASchneiderGHMullerJ. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology. 2005;64(2):344–6.
77.
VercueilLPollakPFraixVCaputoEMoroEBenazzouzA. Deep brain stimulation in the treatment of severe dystonia. J Neurol. 2001;248(8):695–700.
78.
SunBChenSZhanSLeWKrahlSE. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl. 2007;97(Pt 2):207–14.
79.
RosasHDKoroshetzWJJenkinsBGChenYIHaydenDLBealMF. Riluzole therapy in Huntington's disease (HD). Mov Disord. 1999;14(2):326–30.
80.
BonuccelliUCeravoloRMaremmaniCNutiARossiGMuratorioA. Clozapine in Huntington's chorea. Neurology. 1994;44(5):821–3.
81.
MoroELangAEStrafellaAPPoonYYArangoPMDagherA. Bilateral globus pallidus stimulation for Huntington's disease. Ann Neurol. 2004;56(2):290–4.
82.
HebbMOGarciaRGaudetPMendezIM. Bilateral stimulation of the globus pallidus internus to treat choreathetosis in Huntington's disease: Technical case report. Neurosurgery. 2006;58(2):E383.
83.
VandewalleVvan der LindenCGroenewegenHJCaemaertJ. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet. 1999;353(9154):724.
84.
Visser-VandewalleVTemelYBoonPVreelingFColleHHooglandG. Chronic bilateral thalamic stimulation: A new therapeutic approach in intractable Tourette syndrome: Report of three cases. J Neurosurg. 2003;99(6):1094–100.
85.
HouetoJLKarachiCMalletLPillonBYelnikJMesnageV. Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry. 2005;76:992–5.
86.
MinkJWWalkupJFreyKAComoPCathDDelongMR; Tourette Syndrome Association, Inc. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006;21(11):1831–8.
